Skip to main content

Rheumatoid Arthritis

      Rheumatology Round-Up with Drs. Kavanaugh & Cush

      The Annual Review of Best ACR 2020 abstracts featuring Drs. Cush and Kavanaugh filmed on the last day of Virtual ACR 2020 Nov. 9, 2020.

      A Review of RA Studies at ACR: Dr. Janet Pope

      Dr. Janet Pope reviews #0483, #0187, #1715, #0151 and #1736 presented at the 2020 ACR annual meeting.

      Lifestyle and Risk of RA, Lupus: Dr. Janet Pope

      Dr. Janet Pope reviews abstracts #1198 and #1473 presented at the 2020 ACR annual meeting.

      New ACR RA Guidelines and Practice Changing Abstracts: RA Panel

      Dr. Jonathan Kay leads an international panel on the new ACR RA guidelines and other practice-changing abstracts presented at the 2020 ACR annual meeting. Panelists include Dr.Kathryn Dao, Dr. Eric Dein, Dr. Meral El Ramahi, Dr. Richard Conway and Dr. Sheila Reyes. 

      Cardiovascular Risk on MTX in Rheumatoid Arthritis: Dr. Jonathan Kay

      Dr. Jonathan Kay reviews several studies that look at the cardiovascular risk of methotrexate in people with rheumatoid arthritis. 

      Vaccination with Shingrix: Does it work for patients on JAKi?

      Dr. Jeffrey Curtis examines abstracts #1997 and #0452 presented at the ACR 2020 annual meeting.

      Patient Outcomes on Low-Dose Steroids: Dr. Eric Dein

      Dr. Eric Dein reviews abstract #1998 presented at the 2020 ACR annual meeting.

      Mid-Meeting Recap: Rheumatoid Arthritis

      On Saturday, November 7th, Drs. Cush and Kavanaugh discuss rheumatoid arthritis studies presented at ACR 2020 with Dr. Kathryn Dao and Dr. Jonathan Kay.

      Addressing Fatigue in Rheumatoid Arthritis: Dr Eric Dein

      Dr. Eric Dein reviews abstract #1737 at the 2020 ACR Annual Meeting.

      Flu and Tofacitinib: Dr. Kathryn Dao

      Dr. Kathryn Dao reviews abstract L04 at the 2020 ACR annual meeting.

      Who has more comorbidities? Dr. Janet Pope

      Dr. Janet Pope reviews abstract #1466 presented at the 2020 ACR annual meeting. Who has more comorbidities: OA, Gout, RA or PsA? 

      Hepatitis B, RA and Drug Risk with Drs. Stanley Cohen and Jack Cush

      Dr. Cush interviews past ACR president and long-time friend Dr. Stan Cohen on treatment for liver disease in RA patients and new guidelines being released this morning at ACR 2020.

      ABCs of RA: Panel Discussion with Dr. Jonathan Kay

      They're back: from Dublin, Melbourne, Boston, Baltimore and Quezon City, Philippines to discuss top abstracts in the area of RA at the end of day three (Sunday) at ACR 2020, led by Dr. Jonathan Kay. Panelists: Dr. Sheila Reyes, Dr. David Liew, Dr. Eric Dein and Dr. Richard Conway.

      Gut Microbiome and RA: Dr. Robert Chao interviews Dr. Monica Guma

      Dr. Monica Guma reviews her Monday abstract presentation on gut microbiome and improvement in RA (abstract #1994), being presented at the 2020 ACR annual meeting.

      CV Risk in Rheumatoid Arthritis and Osteoarthritis: Dr. Eric Dein

      Dr. Eric Dein reviews abstract #1189 (from the PRECISION trial) presented at the 2020 ACR annual meeting.

      ×